Gossamer Bio

Yahoo Finance • 8 hours ago

Analysts Remain Bullish on Gossamer Bio (GOSS) Despite Phase 3 Setback

Gossamer Bio, Inc. (NASDAQ:GOSS) earns a spot on our list of the best penny stocks set to explode.Analysts Remain Bullish on Gossamer Bio (GOSS) Despite Phase 3 Setback As of April 8, 2026, sentiment around Gossamer Bio, Inc. (NASDAQ:GOSS... Full story

Yahoo Finance • 2 days ago

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (NASDAQ: GOSS) for v... Full story

Yahoo Finance • 3 days ago

DEADLINE ALERT for GOSS, NUAI, MEDP, and STLA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the... Full story

Yahoo Finance • 6 days ago

Cantor Fitzgerald Downgrades Gossamer Bio (GOSS) to Neutral

Gossamer Bio, Inc. (NASDAQ:GOSS) is one of the 8 Most Oversold Penny Stocks to Buy Right Now. On March 23, 2026, Cantor Fitzgerald downgraded Gossamer Bio, Inc. (NASDAQ:GOSS) to Neutral from Overweight without a price target. Cantor Fitz... Full story

Yahoo Finance • 11 days ago

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Gossamer (GOSS) To Contact Him Directly To Discuss Their Options If you purchased or acquired Gossamer securities between June 16, 2... Full story

Yahoo Finance • 12 days ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (GOSS)

NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons o... Full story

Yahoo Finance • 12 days ago

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Gossamer Bio, Inc. (GOSS) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Gossamer Bio, Inc. (“Gossamer Bio” or the “Company”) (NASDAQ: GOSS). The lawsuit alleges that Defendants issued false and misleading s... Full story

Yahoo Finance • 19 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Gossamer Bio, Inc. – GOSS

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS). Such investors are advised to contact Danielle Peyton at newact... Full story

Yahoo Finance • 20 days ago

Gossamer Bio downgraded by Cantor on unclear regulatory path for seralutinib

[Wall street] * Cantor Fitzgerald has downgraded Gossamer Bio (GOSS [https://seekingalpha.com/symbol/GOSS]) to neutral from overweight citing uncertainty in the regulatory path for seralutinib as a treatment for pulmonary arterial hyper... Full story

Yahoo Finance • last month

Gossamer Bio options imply 46.1% move in share price post-earnings

Pre-earnings options volume in Gossamer Bio (GOSS) is normal with puts leading calls 19:3. Implied volatility suggests the market is anticipating a move near 46.1%, or 0c, after results are released. Median move over the past eight quarter... Full story

Yahoo Finance • last month

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gossamer Bio, Inc. (“Gossamer” or the “Company”) (NASDAQ: GOSS). Such investors are advised to contact Danielle Peyton at newact... Full story

Yahoo Finance • last month

Catalyst Watch: Jobs report, new Apple products, and a spotlight on software

[New York Stock Exchange] Selcuk Oner/iStock Editorial via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock pric... Full story

Yahoo Finance • 2 months ago

Qualcomm, Booking Holdings upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Loop Capital upgraded Qualcomm (QCOM)... Full story

Yahoo Finance • 2 months ago

Analysts Remain Bullish on Gossamer Bio (GOSS) Citing Undervaluation

Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best stocks under $3 to invest in. On February 4, H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Gossamer Bio and set a $10 price target on the stock. This ratings confirma... Full story

Yahoo Finance • 6 months ago

Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream

MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies c... Full story

Yahoo Finance • 6 months ago

Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.

MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies c... Full story

Yahoo Finance • 7 months ago

H.C. Wainwright Asserts Buy Stance on Gossamer Bio Inc. (GOSS) on Pulmonary Arterial Hypertension Drug Prospects

Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best Robinhood penny stocks to invest in. The stock has shown strong momentum, rallying by more than 100% year to date. Likewise, on August 19, analysts at H.C. Wainwright reiterated a ‘Buy’ ra... Full story

Yahoo Finance • 7 months ago

Gossamer Bio higher as UBS upgrades on upcoming data catalyst

[Wall Street New York stock exchange stock market] alexsl Shares of Gossamer Bio (NASDAQ:GOSS [https://seekingalpha.com/symbol/GOSS]) traded higher on Wednesday after UBS upgraded the California-based biotech to Buy from Neutral, citing a... Full story

Yahoo Finance • 8 months ago

Gossamer Bio GAAP EPS of -$0.17 in-line, revenue of $11.49M beats by $6.08M

* Gossamer Bio press release [https://seekingalpha.com/pr/20189999-gossamer-bio-announces-second-quarter-2025-financial-results-and-provides-business-update] (NASDAQ:GOSS [https://seekingalpha.com/symbol/GOSS]): Q2 GAAP EPS of -$0.17 in-... Full story

Yahoo Finance • 11 months ago

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies compan... Full story